Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Steve W Ludmerer"'
Autor:
Trevor J Morin, Teresa J Broering, Brett A Leav, Barbra M Blair, Kirk J Rowley, Elisabeth N Boucher, Yang Wang, Peter S Cheslock, Michael Knauber, David B Olsen, Steve W Ludmerer, Gyongyi Szabo, Robert W Finberg, Robert H Purcell, Robert E Lanford, Donna M Ambrosino, Deborah C Molrine, Gregory J Babcock
Publikováno v:
PLoS Pathogens, Vol 8, Iss 8, p e1002895 (2012)
Hepatitis C virus (HCV) infection is a leading cause of liver transplantation and there is an urgent need to develop therapies to reduce rates of HCV infection of transplanted livers. Approved therapeutics for HCV are poorly tolerated and are of limi
Externí odkaz:
https://doaj.org/article/8744314b7609471e91dbe560c056d0b8
Autor:
Fumitaka Suzuki, Hiromitsu Kumada, Go Fujimoto, Yoshiyasu Karino, Steve W. Ludmerer, Satoshi Mochida, Keisuke Nakamura, Anita Y. M. Howe, Niloufar Mobashery, Kazuaki Chayama
Publikováno v:
Journal of gastroenterology and hepatology. 31(10)
Background and Aim Vaniprevir is a macrocyclic hepatitis C virus (HCV) non-structural (NS)3/4A protease inhibitor. The objective of these phase 3 multicenter, open-label trials was to evaluate the safety and efficacy of vaniprevir + peginterferon alf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6882eafb69cc4a3d3ef722d016699263
https://pubmed.ncbi.nlm.nih.gov/26936417
https://pubmed.ncbi.nlm.nih.gov/26936417
Autor:
Steve W. Ludmerer, John F. Fay, Giovanni Migliaccio, Jay A. Grobler, Eric J. Markel, Osvaldo A. Flores, Amy L. Simcoe, Donald J. Graham, Edward M. Murray
Publikováno v:
The Journal of biological chemistry. 278(19)
Efficient replication of hepatitis C virus (HCV) replicons in cell culture is associated with specific sequences not generally observed in vivo. These cell culture adaptive mutations dramatically increase the frequency with which replication is estab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f88ebe22654714752bba1642ce65bd04
https://pubmed.ncbi.nlm.nih.gov/12615931
https://pubmed.ncbi.nlm.nih.gov/12615931
Autor:
Peter S. Cheslock, Deborah C. Molrine, Kirk J. Rowley, Trevor J. Morin, Robert E. Lanford, David B. Olsen, Gyongyi Szabo, Elisabeth N. Boucher, Robert H. Purcell, Donna M. Ambrosino, Steve W. Ludmerer, Yang Wang, Teresa J. Broering, Gregory J. Babcock, Brett Leav, Barbara M. Blair, Robert W. Finberg, Michael Knauber
Publikováno v:
PLoS Pathogens
PLoS Pathogens, Vol 8, Iss 8, p e1002895 (2012)
PLoS Pathogens, Vol 8, Iss 8, p e1002895 (2012)
Hepatitis C virus (HCV) infection is a leading cause of liver transplantation and there is an urgent need to develop therapies to reduce rates of HCV infection of transplanted livers. Approved therapeutics for HCV are poorly tolerated and are of limi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::363471029edc57e65e1a0a3279ae7d1d
https://doi.org/10.1371/journal.ppat.1002895
https://doi.org/10.1371/journal.ppat.1002895
Autor:
Nigel J. Liverton, Mike Rudd, Christine Fandozzi, Carolyn McHale, John A. McCauley, Christine Burlein, Adam Gates, Steve W. Ludmerer, Don Graham, S S Carroll, Daria J. Hazuda, Jill DiMuzio, Paul J. Coleman, David B. Olsen, Mark Stahlhut, Joe Vacca
Publikováno v:
Antiviral Research. 86:A21
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::79ee9e5c3ce70a30014be942229b4508
https://doi.org/10.1016/j.antiviral.2010.02.337
https://doi.org/10.1016/j.antiviral.2010.02.337